Functional role of CD26 on human B lymphocytes

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• CD26 is a known T cell and NK cell activation marker, identical to dipeptidyl peptidase IV (DP IV).
• The expression of CD26 on B cells remains controversial.
• CD26's role in B cell activation requires further investigation.

Purpose of the Study:

• To investigate CD26 expression on B cells from healthy donors and CVID patients.
• To determine the effect of DP IV inhibitors on B cell activation and DNA synthesis.

Main Methods:

• Studied CD26 expression on peripheral blood B cells, Burkitt lymphoma cell line (Daudi), and EBV-transformed B-cell lines (Jojo, Laz509).
• Utilized anti-CD26 monoclonal antibodies and specific enzyme substrates for detection.
• Assessed the impact of specific synthetic DP IV inhibitors on mitogenic activation and DNA synthesis.

Main Results:

• Freshly isolated CD20-positive B cells showed 0-5% CD26 expression.
• Stimulation increased CD26 expression to 51% (pokeweed mitogen) and 36% (St. aureus protein).
• DP IV inhibitors significantly inhibited B cell DNA synthesis in a dose-dependent manner.

Conclusions:

• CD26 is an activation marker for a major B cell population.
• CD26 expression on B cells from CVID patients mirrors that of healthy donors.
• CD26 likely plays a role in B cell activation, with potential therapeutic implications.